Common Scientific Advisory Board (SAB) between CRKI and Karolinska CCC
A common international Scientific Advisory Board between Cancer Research KI and the Karolinska Comprehensive Cancer Center (Karolinska CCC) has been established. The board of directors of the KCCC, representing both the Karolinska Institute and The Karolinska University Hospital, aimed to incorporate advisory members with broad expertise in clinical, basic and caring cancer research; covering a varied set of cancer subdisciplines.
This common SAB will be able to advise on matters including, but not limited to, the long-term strategic development of research, education, care and prevention within cancer for both Cancer Research KI and the Karolinska CCC. The current members of the SAB are listed below in the table.
| Title / Name | Institution | Country |
|---|---|---|
| Prof. Kjetil Taskén | University of Oslo, Oslo University Hospital | Norway |
| Prof. Åslaug Helland | Oslo University Hospital, Oslo Comprehensive Cancer Center | Norway |
| Prof. Lodewyk Wessels | Netherlands Cancer Institute (NKI) | The Netherlands |
| Prof. Heinz-Peter Schlemmer | German Cancer Research Center (DKFZ), Heidelberg | Germany |
| Dr. Suzette Delaloge | Gustave Roussy | France |
| Prof. Mary Wells | Imperial College London | United Kingdom |
| Prof. Christina Peters | St. Anna Children's Hospital | Austria |
| Prof. Ulrike Köhl | Fraunhofer Institute for Cell Therapy and Immunology | Germany |
| Prof. Andreas Rosenwald | Würtzburg University | Germany |
| Dr. Laura Esserman | University of California San Francisco | USA |
| Prof. Julian Downward | Francis Crick Institute | United Kingdom |
| Prof. Nancy Berliner | Brigham and Women's Hospital, Harvard Medical School | USA |
Scientific Advisory Board Visits
Photo: N/ARecap from Scientific Advisory Board (SAB) visit, May 2023
Here is a short recap from the latest Scientific Advisory Board (SAB), visit to Karolinska CCC on May 15-16th, 2023.